Journal of Thrombosis and Haemostasis
© International Society on Thrombosis and Haemostasis
Edited By: Pieter Reitsma and Frits Rosendaal
Impact Factor: 5.565
ISI Journal Citation Reports © Ranking: 2015: 6/63 (Peripheral Vascular Disease); 10/70 (Hematology)
Online ISSN: 1538-7836
Associated Title(s): Research and Practice in Thrombosis and Haemostasis
Recently Published Issues
Special Issues from JTH
Compilations from JTH
Read now, a new Antiphospholipids Compilation of popular JTH articles on the subject of antiphospholipid antibodies published since 2011!
Read now, a new Platelet Compilation of popular JTH articles on the subject of platelets published since 2011!
Read now, a new SSC Recommendations and Guidelines Compilation!
Read now, a new Women's Health Compilation of popular JTH articles on the subject of women's health published since 2010!
Available Now, a Hemophilia Compilation of the most popular manuscripts on the subject of hemophilia published in JTH since 2010. Explore the table of contents and discover the important research published on this topic in JTH!
Also available, a Direct Oral Anticoagulants Compilation
Read now, JTH's Editorial Compilation of all Editorials published in JTH since 2013.
Now available! The new 2015 State of the Art issue from Journal of Thrombosis and Haemostasis (JTH)™, the definitive collection of topical reviews in thrombosis and hemostasis written by internationally acclaimed experts in the field. Access is free to this issue!
Click here to learn more and download free!
This Month in JTH
Schematic representation of profibrotic effects of protease-activated receptors (PARs) in different cell types
The April review article discusses whether cellular receptors that form part of the coagulation system are therapeutic targets in idiopathic pulmonary fibrosis.
Is there clinical benefit of hospitalization versus outpatient management of patients with pulmonary embolism? This question is answered in an original article by P. M. Roy and colleagues.
Recombinant coagulation factor VIII is notoriously difficult to produce. An attempt at optimising codon-usage can be found in the ‘Coagulation’ category of this month’s issue.
Targeting coagulation factor receptors – protease-activatedreceptors in idiopathic pulmonary ﬁbrosis
C. Lin, K. Borensztajn and C. A. Spek
Net clinical beneﬁt of hospitalization versus outpatientmanagement of patients with acute pulmonary embolism
P.-M. Roy, D J. Corsi, M. Carrier, A. Theogene, C. de Wit, C. Dennie, G. Le Gal, A. Delluc, T. Moumneh, M. Rodger, P. Wells and E. Gandara
Expression and characterization of a codon-optimized bloodcoagulation factor VIII
S. A. Shestopal, J-J. Hao, E. Karnaukhova, Y. Liang, M. V. Ovanesov, M. Lin, J. H. Kurasawa, T. K. Lee, J. H. McVey and A. G. Sarafanov
Top Reasons to Submit Your Research to Journal of Thrombosis and Haemostasis (JTH)
• High 2014 Impact Factor: 5.720
• Rapid publication of Accepted Articles online, ahead of print and before copy-editing
• Publication of final articles in Early View, ahead of print
• Easy online submission at http://mc.manuscriptcentral.com/jth
• Prime exposure to all ISTH members and international experts in the field
• Join the ranks of top cited and most read researchers publishing in this authoritative publication
• Submission to first decision of 19 days
Yet another benefit when you choose to publish in JTH™!
JTH™ supports authors by posting the accepted versions of articles by NIH grant-holders to PubMed Central upon acceptance by the journal. We do this automatically for you.
Read the full details on our policy regarding the deposit of articles for research funded by the NIH in the mandate that became effective on 7 April 2008.
Journal and ISTH News
ISTH Membership. To ensure that you receive continued access to the JTH, renew your ISTH membership. Get started today.
Click to read JTH's new article: Global public awareness of venous thromboembolism
The first World Thrombosis Day, led by the ISTH, was on October 13, 2014, and was marked with the JTH Open Access article titled, “Thrombosis: a major contributor to the global disease burden.” To read the article, click on the image below.